Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01740115 · ClinicalTrials.gov registry record
Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 250
- Enrollment target
NCT01740115 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 250 participants.
The verdict
NCT01740115 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to expand and continue a cohort of HIV-infected adults to establish the longitudinal Boston ARCH Cohort of 250 HIV-infected men and women with current substance dependence or ever injection drug use that have a spectrum of alcohol use; and to determine the effect of alcohol consumption on changes in bone health prospectively in the Cohort.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2012-11 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01740115
The ClinicalTrials.gov registry entry for NCT01740115 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01740115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01740115 about?
NCT01740115 is a clinical study titled "Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort". The purpose of this study is to expand and continue a cohort of HIV-infected adults to establish the longitudinal Boston ARCH Cohort of 250 HIV-infected men and women with current substance dependence or ever injection drug use that have a spectrum of alcohol use; and to determine the effect of alco...
What is the current status of trial NCT01740115?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2012-11. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT01740115?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.